MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1164/rccm.202206-1118oc

Медицинская библиотека · American journal of respiratory and critical care medicine · 2023

A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase Tuberculosis Clinical Trials.

Kurbatova Ekaterina V, Phillips Patrick P J, Dorman Susan E, Sizemore Erin E, Bryant Kia E, Purfield Anne E, Ricaldi Jessica, Brown Nicole E, Johnson John L, Wallis Carole L, Akol Joseph P, Ocheretina Oksana, Van Hung Nguyen, Mayanja-Kizza Harriet, Lourens Madeleine, Dawson Rodney, Nhung Nguyen Viet, Pierre Samuel, Musodza Yeukai, Shenje Justin, Badal-Faesen Sharlaa, Vilbrun Stalz Charles, Waja Ziyaad, Peddareddy Lakshmi, Scott Nigel A, Yuan Yan, Goldberg Stefan V, Swindells Susan, Chaisson Richard E, Nahid Payam

Клиническое исследованиеСтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Rationale: We developed a standardized method, possible poor treatment response (PPTR), to help ascertain efficacy endpoints in Study S31/A5349 (NCT02410772), an open-label trial comparing two 4-month rifapentine-based regimens with a standard 6-month regimen for the treatment of pulmonary tuberculosis (TB).

Objectives

We describe the use of the PPTR process and evaluate whether the goals of minimizing bias in efficacy endpoint assessment and attainment of relevant data to determine outcomes for all participants were achieved.

Methods

A PPTR event was defined as the occurrence of one or more prespecified triggers. Each PPTR required initiation of a standardized evaluation process that included obtaining multiple sputum samples for microbiology. Measurements and Main

Results

Among 2,343 participants with culture-confirmed drug-susceptible TB, 454 individuals (19.4%) had a total of 534 individual PPTR events, of which 76.6% were microbiological (positive smear or culture at or after 17 wk). At least one PPTR event was experienced by 92.4% (133 of 144) of participants with TB-related unfavorable outcome and between 13.8% and 14.7% of participants with favorable and not-assessable outcomes. A total of 75% of participants with TB-related unfavorable outcomes had microbiological confirmation of failure to achieve a disease-free cure.

Conclusions

Standardized methodologies, such as our PPTR approach, could facilitate unbiased efficacy outcome determinations, improve discrimination between outcomes that are related and unrelated to regimen efficacy, and enhance the ability to conduct pooled analyses of contemporary trials.

Для цитирования: Kurbatova Ekaterina V, Phillips Patrick P J, Dorman Susan E, Sizemore Erin E, Bryant Kia E, Purfield Anne E, Ricaldi Jessica, Brown Nicole E, Johnson John L, Wallis Carole L, Akol Joseph P, Ocheretina Oksana, Van Hung Nguyen, Mayanja-Kizza Harriet, Lourens Madeleine, Dawson Rodney, Nhung Nguyen Viet, Pierre Samuel, Musodza Yeukai, Shenje Justin, Badal-Faesen Sharlaa, Vilbrun Stalz Charles, Waja Ziyaad, Peddareddy Lakshmi, Scott Nigel A, Yuan Yan, Goldberg Stefan V, Swindells Susan, Chaisson Richard E, Nahid Payam. A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase Tuberculosis Clinical Trials.. American journal of respiratory and critical care medicine. 2023. DOI: 10.1164/rccm.202206-1118oc.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.